98737-30-5

Basic information

• Product Name: (2R,3S,1'R)-3-(t-Boc-amino)-2-hydroxy-4-phenyl-1-<(1-phenylethyl)amino>butane
• Synonyms: (2R,3S,1'R)-3-(t-Boc-amino)-2-hydroxy-4-phenyl-1-<(1-phenylethyl)amino>butane
• CAS NO: 98737-30-5
• Molecular Weight: 384.519
• Mol File: 98737-30-5.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: (2R,3S,1'R)-3-(t-Boc-amino)-2-hydroxy-4-phenyl-1-<(1-phenylethyl)amino>butane(CAS DataBase Reference)
• NIST Chemistry Reference: (2R,3S,1'R)-3-(t-Boc-amino)-2-hydroxy-4-phenyl-1-<(1-phenylethyl)amino>butane(98737-30-5)
• EPA Substance Registry System: (2R,3S,1'R)-3-(t-Boc-amino)-2-hydroxy-4-phenyl-1-<(1-phenylethyl)amino>butane(98737-30-5)

Safety Data

• Hazardous Substances Data: 98737-30-5(Hazardous Substances Data)

Upstream product

• 960041-86-5 C₄H₉COOHNCH(CH₂C₆H₅)CH(OH)CH₂I 
• 3886-69-9 (R)-1-phenyl-ethyl-amine 
• 103127-53-3 N-tert-butyloxycarbonyl-2-amino-3-phenylpropionaldehyde 
• 220871-52-3 1(R,S)-<1'-(S)-<(tert-butyloxycarbonyl)amino>-2-phenylethyl>oxirane 
• 98760-08-8 (1-oxiranyl-2-phenylethyl)carbamic acid tert-butyl ester 

Downstream Products

• 1422208-26-1 C₃₇H₄₄N₄O₃ 
• 1422208-25-0 C₃₈H₄₈N₄O₃ 
• 1422208-24-9 C₃₆H₄₄N₄O₃ 
• 1422208-23-8 C₃₆H₄₂N₄O₃ 
• 1422208-22-7 C₃₈H₄₈N₄O₃ 
• 1422208-21-6 C₃₆H₄₄N₄O₃ 
• 1422208-20-5 C₃₁H₃₉N₃O₃ 
• 1422208-19-2 C₃₀H₃₇N₃O₃ 
• 1422208-18-1 C₃₂H₄₃N₃O₃ 
• 1422208-17-0 C₃₀H₃₉N₃O₃ 
• 1422208-48-7 (2R,3S)-3-amino-4-phenyl-1-(((R)-1-phenylethyl)amino)butan-2-ol hydrochloride 
• 1422207-90-6 C₃₁H₃₄N₄O₂ 
• 1422207-89-3 C₃₀H₃₂N₄O₂ 
• 1422207-87-1 C₃₂H₃₆N₄O₂ 

Relevant articles and documents

Novel in vivo active anti-malarials based on a hydroxy-ethyl-amine scaffold

A novel series of anti-malarials, based on a hydroxy-ethyl-amine scaffold, initially identified as peptidomimetic protease inhibitors is described. Combination of the hydroxy-ethyl-amine anti-malarial phramacophore with the known Mannich base pharmacophor

HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE

The present invention relates to novel hydroxyethylamine compounds of formula (I): (I) having Asp2 (-secretase, BACE1 or Memapsin) inhibitory activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases characterised by elevated-amyloid levels or-amyloid deposits, particularly Alzheimer's disease.